Promising research trials find new combination of drugs treat underlying cause of most common form of cystic fibrosis

Results from clinical trials show that a new combination of medications can successfully treat the underlying cause of cystic fibrosis for patients 12 and older with two copies of the F508del gene mutation -- the most common form of the life-threatening, genetic disease found in over half of the CF population.